Summary of Key Information:
Reporting Period (Quarter/Year): Q2 and Half Year Ended September 30, 2026
Nature of Filing / Announcement: Outcome of Board Meeting pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015
Audit Opinion:
Unmodified opinion (clean) from statutory auditors Kalyaniwalla & Mistry LLP on both standalone and consolidated financial results
Key Financial Highlights [Rs. in Lakhs]:
Standalone Results:
Revenue from Operations (Q2 FY27): ₹1,95,669.83 (Q2 FY26: ₹1,10,015.18, YoY increase of 77.9%)
Total Income (Q2 FY27): ₹1,96,805.71
Net Profit (Q2 FY27): ₹9,492.55 (Q2 FY26: ₹4,819.80, YoY increase of 97%)
EPS (Q2 FY27): ₹5.05 basic and diluted (Q2 FY26: ₹2.57)
Other Equity: ₹2,51,125.29 as at September 30, 2026 (March 31, 2026: ₹2,33,260.82)
Cash and Cash Equivalents: ₹88,559.46 as at September 30, 2026 (includes ₹17,426.45 cash, ₹24,855.85 unrestricted bank balances, ₹46,277.16 mutual funds)
Debt: Company remains debt-free as per Note 5
Consolidated Results:
Revenue from Operations (H1 FY27): ₹3,69,802.08 (H1 FY26: ₹2,51,966.47, YoY increase of 46.8%)
Total Income (H1 FY27): ₹3,72,683.04
Net Profit Attributable to Owners (H1 FY27): ₹33,350.93 (H1 FY26: ₹13,011.51, YoY increase of 156%)
EPS (H1 FY27): ₹17.74 basic and diluted (H1 FY26: ₹6.92)
Other Equity: ₹2,58,972.19 as at September 30, 2026 (March 31, 2026: ₹2,37,761.68)
Cash and Cash Equivalents: ₹88,559.60 as at September 30, 2026
Segment-wise Performance:
The Group operates in a single reportable business segment: 'Styrenics and Allied Products' as per Ind AS-108
Corporate Actions:
Dividend: Declared Interim Dividend of ₹2.50 per equity share (125%) for FY 2026-2027 on paid-up equity share capital of 188,041,342 equity shares of ₹2 each
Total Dividend Outgo: ₹4,701.03 Lakhs
Record Date: Fixed as Friday, October 30, 2026 for determining eligibility for interim dividend
Other Significant Information:
The company continues to remain debt-free
Finance cost primarily comprises interest expense on lease pertaining to Ind AS 116 Leases
Subsidiary included in consolidation: Xmold Polymers Private Limited
Paid-up Equity Share Capital: ₹3,760.83 Lakhs (face value ₹2 per share)